Zhao GN - Search Results

1

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

Xie L, Wang PX, Zhang P, Zhang XJ, Zhao GN, Wang A, Guo J, Zhu X, Zhang Q, Li H. Xie L, et al. Among authors: zhao gn. J Hepatol. 2016 Jul;65(1):113-124. doi: 10.1016/j.jhep.2016.03.008. Epub 2016 Mar 23. J Hepatol. 2016. PMID: 27016281

2

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Hu J, Zhu XH, Zhang XJ, Wang PX, Zhang R, Zhang P, Zhao GN, Gao L, Zhang XF, Tian S, Li H. Hu J, et al. Among authors: zhao gn. J Hepatol. 2016 Jan;64(1):146-59. doi: 10.1016/j.jhep.2015.08.021. Epub 2015 Aug 31. J Hepatol. 2016. PMID: 26334576

3

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.

Wang PX, Zhang XJ, Luo P, Jiang X, Zhang P, Guo J, Zhao GN, Zhu X, Zhang Y, Yang S, Li H. Wang PX, et al. Among authors: zhao gn. Nat Commun. 2016 Feb 17;7:10592. doi: 10.1038/ncomms10592. Nat Commun. 2016. PMID: 26882989 Free PMC article.

4

Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke.

Gong J, Li ZZ, Guo S, Zhang XJ, Zhang P, Zhao GN, Gao L, Zhang Y, Zheng A, Zhang XF, Xiang M, Li H. Gong J, et al. Among authors: zhao gn. Hypertension. 2015 Sep;66(3):604-16. doi: 10.1161/HYPERTENSIONAHA.115.05430. Epub 2015 Jul 27. Hypertension. 2015. PMID: 26269654

5

Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.

Zhu X, Fang J, Gong J, Guo JH, Zhao GN, Ji YX, Liu HY, Wei X, Li H. Zhu X, et al. Among authors: zhao gn. Hypertension. 2016 May;67(5):866-77. doi: 10.1161/HYPERTENSIONAHA.115.07042. Epub 2016 Mar 28. Hypertension. 2016. PMID: 27021007

6

Oncostatin M Confers Neuroprotection against Ischemic Stroke.

Guo S, Li ZZ, Gong J, Xiang M, Zhang P, Zhao GN, Li M, Zheng A, Zhu X, Lei H, Minoru T, Li H. Guo S, et al. Among authors: zhao gn. J Neurosci. 2015 Aug 26;35(34):12047-62. doi: 10.1523/JNEUROSCI.1800-15.2015. J Neurosci. 2015. PMID: 26311783 Free PMC article.

7

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.

Zhao GN, Zhang P, Gong J, Zhang XJ, Wang PX, Yin M, Jiang Z, Shen LJ, Ji YX, Tong J, Wang Y, Wei QF, Wang Y, Zhu XY, Zhang X, Fang J, Xie Q, She ZG, Wang Z, Huang Z, Li H. Zhao GN, et al. Nat Med. 2017 Jun;23(6):742-752. doi: 10.1038/nm.4334. Epub 2017 May 8. Nat Med. 2017. PMID: 28481357

8

Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.

Deng KQ, Zhao GN, Wang Z, Fang J, Jiang Z, Gong J, Yan FJ, Zhu XY, Zhang P, She ZG, Li H. Deng KQ, et al. Among authors: zhao gn. Circulation. 2018 Apr 3;137(14):1486-1504. doi: 10.1161/CIRCULATIONAHA.117.031659. Epub 2017 Dec 11. Circulation. 2018. PMID: 29229612

9

TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease.

Zhao GN, Tian ZW, Tian T, Zhu ZP, Zhao WJ, Tian H, Cheng X, Hu FJ, Hu ML, Tian S, Ding T, Chen S, Ji YX, Zhang P, Zhang XJ, She ZG, Yuan Y, Chen W, Bai L, Li H. Zhao GN, et al. Among authors: zhao wj. Cell Metab. 2021 Aug 3;33(8):1640-1654.e8. doi: 10.1016/j.cmet.2021.05.014. Epub 2021 Jun 8. Cell Metab. 2021. PMID: 34107313 Free article.

10

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.

Zhao GN, Jiang DS, Li H. Zhao GN, et al. Biochim Biophys Acta. 2015 Feb;1852(2):365-78. doi: 10.1016/j.bbadis.2014.04.030. Epub 2014 May 5. Biochim Biophys Acta. 2015. PMID: 24807060 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page